{
    "Trade/Device Name(s)": [
        "Pathwork Tissue of Origin Test Kit-FFPE"
    ],
    "Submitter Information": "Pathwork Diagnostics, Inc.",
    "510(k) Number": "K120489",
    "Predicate Device Reference 510(k) Number(s)": [
        "K092967"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OIW"
    ],
    "Summary Letter Date": "February 15, 2012",
    "Summary Letter Received Date": "February 17, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.3100"
    ],
    "Regulation Name(s)": [
        "Amphetamine Test System"
    ],
    "Analyte Class(es)": [
        "genetic molecular",
        "cancer molecular"
    ],
    "Analyte(s)": [
        "RNA expression patterns",
        "cDNA"
    ],
    "Specimen Type(s)": [
        "Formalin-fixed, paraffin-embedded (FFPE) tumor tissue"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Pathchip microarray",
        "Hybridization oven",
        "Scanner"
    ],
    "Method(s)/Technology(ies)": [
        "Microarray analysis",
        "Gene expression analysis",
        "Machine learning algorithm"
    ],
    "Methodologies": [
        "Gene expression profiling",
        "Microarray",
        "Similarity score algorithm"
    ],
    "Submission Type(s)": [
        "Test Kit",
        "Reagent",
        "Software",
        "Microarray"
    ],
    "Document Summary": "FDA 510(k) summary for Pathwork Tissue of Origin Test Kit-FFPE, a gene expression microarray-based diagnostic for tissue origin determination in FFPE tumor specimens",
    "Indications for Use Summary": "Intended to measure the similarity between RNA expression patterns in a patient\u2019s FFPE tumor and a database of fifteen tumor types for diagnostic assessment by a qualified physician, not for distinguishing tumors outside the database or predicting disease course.",
    "fda_folder": "Toxicology"
}